IRMD
Iradimed Co
NASDAQ: IRMD · HEALTHCARE · MEDICAL DEVICES
$83.71
-0.92% today
Updated 2026-04-29
Market cap
$1.07B
P/E ratio
47.83
P/S ratio
12.77x
EPS (TTM)
$1.75
Dividend yield
0.84%
52W range
$50 – $108
Volume
0.1M
Iradimed Co (IRMD) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+6.8%
Last 4 quarters
Revenue YoY growth
+17.0%
Most recent quarter
EPS YoY growth
+35.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+4.7%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
+21.2%
2025-08-01
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-11 | $0.54 | +16.1% | $105.15 | $99.84 | -5.0% |
| 2025-10-30 | $0.47 | +2.2% | $78.31 | $76.81 | -1.9% |
| 2025-08-01 | $0.49 | +11.4% | $58.34 | $70.69 | +21.2% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $0.47 | $0.54 | +16.1% | $22.69M | +17.0% |
| 2025-09-30 | $0.46 | $0.47 | +2.2% | $21.20M | +15.7% |
| 2025-06-30 | $0.44 | $0.49 | +11.4% | $20.41M | +13.8% |
| 2025-03-31 | $0.38 | $0.37 | -2.6% | $19.51M | +10.9% |
| 2024-12-31 | $0.41 | $0.40 | -2.4% | $19.39M | +11.1% |
| 2024-09-30 | $0.39 | $0.43 | +10.3% | $18.33M | +11.0% |
| 2024-06-30 | $0.37 | $0.42 | +13.5% | $17.93M | +11.1% |
| 2024-03-31 | $0.34 | $0.36 | +5.9% | $17.60M | — |
| 2023-12-31 | $0.40 | $0.39 | -2.5% | $17.45M | — |
| 2023-09-30 | $0.36 | $0.43 | +19.4% | $16.50M | — |
| 2023-06-30 | $0.31 | $0.36 | +16.1% | $16.13M | — |
Frequently asked questions
Has Iradimed Co beaten earnings estimates?
Iradimed Co has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +6.8% over the last 4 quarters.
How does IRMD stock react to earnings?
IRMD stock has moved an average of +4.7% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.
What is Iradimed Co's revenue growth rate?
Iradimed Co reported year-over-year revenue growth of +17.0% in its most recent quarter, with EPS growing +35.0% year-over-year.